[Beta-blockaders and cardiovascular therapy: facts and theories. Part I. Introduction, characterization; therapeutic indications: arterial hypertension].
D000319:Adrenergic beta-Antagonists / Q000378:metabolism / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001775:Blood Circulation; D004347:Drug Interactions; D006331:Heart Diseases / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006977:Hypertension, Renal / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000150:complications; D010640:Phenothiazines
D000319:Adrenergic beta-Antagonists; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D010640:Phenothiazines
Beta-bloccanti e terapia cardiovascolare: fatti e teorie. Parte I: Introduzione - caratterizzazione - indicazioni terapeutiche: ipertensione arteriosa.